The Clinical Effectiveness and Safety of Intravesical Mitomycin-C and Gemcitabine Sequential Therapy

Abroad (travel likely)RecruitingPHASE2

Conditions

Bladder Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

National Cancer Center, Goyang-si, South Korea
Contact: Study coordinator (Ho Kyung Seo) · seohk@ncc.re.kr · 82-31-920-1678
Contact: Principal Investigator (Ho Kyung Seo, MD)
Eui Hyun Jung, Ph.D (Sub-investigator)

Study leads

Ho Kyung Seo, MD
Principal Investigator
National Cancer Center, Korea

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

In-home Intravesical Chemotherapy for the Treatment of Bladder Cancer, INVITE Trial

Non-Muscle Invasive Bladder Carcinoma · Stage 0a Bladder Cancer AJCC v8 · Stage I Bladder Cancer AJCC v8

Abroad (travel likely)RecruitingPHASE1, PHASE2

Jacksonville, United States

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

Advanced Solid Tumor · Melanoma · Head and Neck Cancer

Abroad (travel likely)RecruitingPHASE2

Duarte, United States · New Haven, United States

Replacing Invasive Cystoscopy With Urine Testing for Non-muscle Invasive Bladder Cancer Surveillance

Non-muscle-invasive Bladder Cancer

Abroad (travel likely)RecruitingPHASE2

West Haven, United States · Bay Pines, United States

Study of Cretostimogene Given in Patients With Non-Muscle Invasive Bladder Cancer ,Unresponsive to Bacillus-Calmette-Guerin

Non Muscle Invasive Bladder Cancer · High-grade Ta/ T1 Papillary Disease Bladder Cancer

Abroad (travel likely)RecruitingPHASE2

Beijing, China · Chongqing, China